Christina Östberg Lloyd

Senior Vice-President, Reproductive Medicine Maternal Health, Ferring Pharmaceuticals

Christina Lloyd, SVP and Global Head of Ferring Pharmaceuticals’ Reproductive Medicine and Maternal Health, is responsible for leading and overseeing the strategic planning and direction of all aspects of the company’s core therapeutic focus area.

Prior to joining Ferring, Christina was CEO of Pharmiva, a Sweden-based listed femtech company, She has more than 20 years of experience in management positions in pharmaceutical companies such as Novo Nordisk and also previously served as Ferring as Medical Director between 2002 and 2009. Christina holds a medical degree from the Faculty of Medicine, Lund University and is a specialist in Obstetrics and Gynaecology. She also gained a Medical Business Strategy degree at SIMI Copenhagen and Executive Foundation Lund board degree. In addition, she furthered her leadership and management education at Harvard Business and IMD Business School.

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum